Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
Lucid Diagnostics获得纳斯达克延长180天以恢复符合最低买盘价格规则的合规性
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
Lucid Diagnostics获得纳斯达克延长180天以恢复符合最低买盘价格规则的合规性
使用浏览器的分享功能,分享给你的好友吧